Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moia

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Recenti Progressi in Medicina|January 1, 1991
[Medical aspects of thrombosis of the limbs]P M Mannucci, M Moia
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|June 27, 1998
Venous thromboembolism after laparoscopic surgery: two case reports and review of the literatureA Alatri, M Tronci, P Bucciarelli, et al.
Lupus|September 18, 2014
New oral anticoagulants in thrombotic antiphospholipid syndromeC B Chighizola, M Moia, P L Meroni
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|January 1, 1996
[Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family]M Moia, I La Spina, R Padalino, et al.
Pharmacopsychiatry|August 24, 2001
In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transportersM Gobbi, M Moia, L Pirona, et al.
British Journal of Haematology|May 3, 2000
The G1691 --> A mutation of factor V, but not the G20210 --> A mutation of factor II or the C677 --> T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulantsM Galli, G Finazzi, F Duca, et al.
Thrombosis and Haemostasis|March 4, 1999
Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosisR A Ariëns, G Alberio, M Moia, et al.
International Journal of Laboratory Hematology|June 21, 2016
Evaluation of a new PT-INR monitoring system in patients with the antiphospholipid syndromeS Braham, C Novembrino, M Moia, et al.
La Ricerca in Clinica E in Laboratorio|April 1, 1985
An improved method for measuring red blood cell filterabilityM Moia, A Tripodi, E Mozzi, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|April 1, 1997
Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patientsM Moia, G Graziani, P M Tenconi, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Recenti Progressi in Medicina|January 1, 1991
[Medical aspects of thrombosis of the limbs]P M Mannucci, M Moia
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|June 27, 1998
Venous thromboembolism after laparoscopic surgery: two case reports and review of the literatureA Alatri, M Tronci, P Bucciarelli, et al.
Lupus|September 18, 2014
New oral anticoagulants in thrombotic antiphospholipid syndromeC B Chighizola, M Moia, P L Meroni
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|January 1, 1996
[Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family]M Moia, I La Spina, R Padalino, et al.
Pharmacopsychiatry|August 24, 2001
In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transportersM Gobbi, M Moia, L Pirona, et al.
British Journal of Haematology|May 3, 2000
The G1691 --> A mutation of factor V, but not the G20210 --> A mutation of factor II or the C677 --> T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulantsM Galli, G Finazzi, F Duca, et al.
Thrombosis and Haemostasis|March 4, 1999
Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosisR A Ariëns, G Alberio, M Moia, et al.
International Journal of Laboratory Hematology|June 21, 2016
Evaluation of a new PT-INR monitoring system in patients with the antiphospholipid syndromeS Braham, C Novembrino, M Moia, et al.
La Ricerca in Clinica E in Laboratorio|April 1, 1985
An improved method for measuring red blood cell filterabilityM Moia, A Tripodi, E Mozzi, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|April 1, 1997
Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patientsM Moia, G Graziani, P M Tenconi, et al.
Pageof 6